Skip to main content
BioNote, Inc. logo

BioNote, Inc. — Investor Relations & Filings

Ticker · 377740 ISIN · KR7377740006 KO Manufacturing
Open in API
Filings indexed 160 across all filing types
Latest filing 2025-03-18 Audit Report / Informat…
Country KR South Korea
Listing KO 377740

About BioNote, Inc.

https://www.bionote.com/

BioNote, Inc. is a company specializing in in-vitro diagnostics for the animal health industry. It develops, manufactures, and distributes a range of veterinary diagnostic products, including rapid test kits, ELISA kits, point-of-care (POC) analyzers, and biomarker tests. The company's portfolio is based on its research and development of core biological components like antigens and antibodies. Its products are designed for the detection and diagnosis of animal diseases, providing veterinarians with tools for immunochemical and quantitative analysis in clinical settings.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal notification titled '감사보고서 제출' (Submission of Audit Report) filed by Bionote. It provides a summary of the audit opinion (unqualified/proper) and key financial data (assets, liabilities, revenue, profit) for both consolidated and separate financial statements. While it contains financial data, it is a regulatory announcement confirming the submission of the audit report to the exchange, rather than the full annual report document itself. According to the 'Menu vs Meal' rule, this is a report publication announcement. FY 2024
2025-03-18 Korean
사업보고서 (2024.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Bionote, including the independent auditor's opinion, consolidated financial statements (balance sheet, income statement, cash flow, etc.), and detailed notes. It covers the fiscal year ending December 31, 2024. While it contains financial data, it is specifically the formal audit report required by regulatory standards, not a standalone annual report (10-K) or a quarterly report (IR). FY 2024
2025-03-18 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Bionote. It contains the meeting agenda, voting procedures, director activity reports, and governance information. This type of document is a standard proxy statement/notice sent to shareholders to inform them of upcoming votes and provide necessary background information for those votes. In the context of the provided categories, this fits best as a Proxy Solicitation & Information Statement.
2025-03-11 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and contains detailed information regarding the upcoming Annual General Meeting (AGM) of Bionote, including the purpose of the meeting, voting procedures, and proxy solicitation details. This document is a standard regulatory filing used to solicit votes from shareholders for an upcoming meeting. According to the provided definitions, this falls under 'Proxy Solicitation & Information Statement'.
2025-03-11 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Bionote) announcing a significant change in financial structure (30% or more change in revenue or profit/loss). This is a standard 'Earnings Release' (ER) format used in the Korean market (DART system) to provide preliminary financial results before the final audited report is published. It includes key financial metrics like revenue, operating profit, and net income, and explicitly states it is a preliminary report subject to audit. FY 2024
2025-02-25 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount Classification · 100% confidence The document is a regulatory announcement from Bionote regarding the determination of a record date for shareholder registry closure for the purpose of cash/in-kind dividends. This is a standard corporate action announcement related to dividend distribution procedures, which falls under the category of dividend-related notices.
2025-02-25 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.